VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 61 filers reported holding VOR BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $0 | -100.0% | 322 | -98.5% | 0.00% | – |
Q1 2024 | $52 | +8.3% | 21,867 | +1.7% | 0.00% | – |
Q4 2023 | $48 | +4.3% | 21,495 | -0.6% | 0.00% | – |
Q3 2023 | $46 | -30.3% | 21,616 | +2.0% | 0.00% | – |
Q2 2023 | $66 | -93.4% | 21,200 | +11057.9% | 0.00% | – |
Q2 2022 | $1,000 | -98.5% | 190 | -98.2% | 0.00% | – |
Q1 2022 | $65,000 | -47.6% | 10,694 | +0.4% | 0.00% | – |
Q4 2021 | $124,000 | +1.6% | 10,649 | +36.4% | 0.00% | – |
Q3 2021 | $122,000 | -42.2% | 7,806 | -30.9% | 0.00% | – |
Q2 2021 | $211,000 | -43.1% | 11,292 | +31.3% | 0.00% | – |
Q1 2021 | $371,000 | – | 8,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 6,361,723 | $15,077,284 | 3.38% |
RA Capital Management | 22,748,880 | $53,914,846 | 0.69% |
Paradigm Biocapital Advisors LP | 6,457,293 | $15,303,784 | 0.54% |
Sarissa Capital Management LP | 618,000 | $1,464,660 | 0.26% |
Laurion Capital Management LP | 3,182,889 | $7,543,447 | 0.06% |
Artal Group S.A. | 1,000,000 | $2,370,000 | 0.06% |
JOHNSON & JOHNSON | 1,074,658 | $2,546,939 | 0.06% |
Woodline Partners LP | 1,111,123 | $2,633,362 | 0.02% |
BOURGEON CAPITAL MANAGEMENT LLC | 29,450 | $69,797 | 0.01% |
EXCHANGE TRADED CONCEPTS, LLC | 154,436 | $366,013 | 0.01% |